Banzel (Eisai Inc.)
Welcome to the PulseAid listing for the Banzel drug offered from Eisai Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Eisai Inc. |
NON-PROPRIETARY NAME: | rufinamide |
SUBSTANCE NAME: | RUFINAMIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2008-11-14 |
END MARKETING DATE: | 0000-00-00 |
Banzel HUMAN PRESCRIPTION DRUG Details:
Item Description | Banzel from Eisai Inc. |
LABELER NAME: | Eisai Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 200(mg/1) |
START MARKETING DATE: | 2008-11-14 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 62856-582_1a1fe14e-2ba4-415e-b451-6493720f1cb3 |
PRODUCT NDC: | 62856-582 |
APPLICATION NUMBER: | NDA021911 |
Other RUFINAMIDE Pharmaceutical Manufacturers / Labelers: